Patient characteristics | Values |
---|---|
Number | 25 |
Gender | |
Male | 17 (68%) |
Female | 8 (32%) |
Age (years) | |
Median, range | 60 (34 to 74) |
Localization | |
Head | 21 |
Body and/or tail | 4 |
Lymph node status | |
Positive | 16 (64%) |
Negative | 9 (36%) |
Grading | |
G1 | 0 |
G2 | 11 |
G3 | 11 |
G4 | 1 |
Not reported | 2a |
RTX | |
EBRT median dose (range) (n = 26) | 49.6 Gy (36 to 54 Gy) RT |
IORT median dose (range) (n = 7) | IORT: 12 Gy (10 to 15 Gy) |
Concomitant CTX | |
Overall (with gemcitabine) | 23 (92%) |
None | 2 (8%) |
Toxicity | |
Gastrointestinal (I to III°) | 17 |
Haematological (I° to IV°) | 17 |
Grade II | 11 |
Grade III | 5 |
Grade IV | 1 |
Previous tumour resection | None |
Duration resection - onset of RT | |
Median, range [days] | 44 (12 to 100) |
<30 days | 5 |
30 to 50 days | 11 |
>50 days | 9 |